Novo Nordisk Aktie
WKN: 866931 / ISIN: US6701002056
07.05.2025 15:31:35
|
Novo Nordisk Predicts Strong Second Half
Here's our initial take on Novo Nordisk's (NYSE: NVO) fiscal 2025 first-quarter financial report.Novo Nordisk beat earnings estimates but slightly missed top-line revenue expectations. However, the results throughout its business were quite strong, and management gave an upbeat outlook for the rest of the year -- which was exactly what investors were looking for.Let's start with the business results. First, note that Novo Nordisk reports its results in Danish kroner (its local currency), and all of these figures are at constant exchange rates.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Novo Nordisk (spons. ADRs) | 58,70 | 0,86% |
|